| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $22.7M | +1252.5% |
| Cost of Revenue | $6.8M | +2896.0% |
| R&D Expense | $93.8M | +7.9% |
| SG&A Expense | $49.1M | -10.5% |
| Operating Income | -$127.1M | +9.5% |
| Interest Expense | $3.1M | +23.3% |
| Pre-tax Income | -$153.0M | -6.5% |
| Income Tax | -$2.4M | -386.7% |
| Net Income | -$150.7M | -4.2% |
| EPS (Basic) | -$1.18 | -0.9% |
| EPS (Diluted) | -$1.18 | -0.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $68.4M | +22.4% |
| Accounts Receivable | $8.5M | +472.1% |
| Inventory | $3.4M | +68.7% |
| Current Assets | $168.1M | -38.9% |
| Total Assets | $218.9M | -32.1% |
| Current Liabilities | $60.6M | +41.5% |
| Long-term Debt | $23.0M | -28.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$76.0M | +39.3% |
| Capital Expenditures | $6.5M | +177.4% |
| Investing Cash Flow | $90.6M | +381.5% |
| Financing Cash Flow | -$693K | -100.4% |
| Free Cash Flow | -$82.5M | +35.3% |
| Total Liabilities |
| $120.6M |
| +7.3% |
| Stockholders' Equity | $98.3M | -53.2% |